Ignite Creation Date:
2024-05-05 @ 5:19 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00436566
Status:
COMPLETED
Last Update Posted:
2022-08-05
First Post:
2007-02-15
Brief Title:
Doxorubicin and Cyclophosphamide Followed By Trastuzumab Paclitaxel and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery
Sponsor:
Mayo Clinic
Organization:
Mayo Clinic
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-03-16
Start Date Type:
ACTUAL
Primary Completion Date:
2009-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-07-22
Completion Date Type:
ACTUAL
First Submit Date:
2007-02-15
First Submit QC Date:
February 15 2007
Study First Post Date:
2007-02-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2012-11-21
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-07-12
Last Update Post Date:
2022-08-05
Last Update Post Date Type:
ACTUAL